Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.55 - $5.3 $13,514 - $28,090
5,300 Added 38.97%
18,900 $48,000
Q2 2024

Aug 14, 2024

BUY
$5.17 - $8.5 $12,408 - $20,400
2,400 Added 21.43%
13,600 $73,000
Q1 2024

May 15, 2024

SELL
$5.1 - $7.78 $28,049 - $42,790
-5,500 Reduced 32.93%
11,200 $82,000
Q4 2023

Feb 14, 2024

SELL
$4.15 - $7.2 $42,330 - $73,440
-10,200 Reduced 37.92%
16,700 $88,000
Q3 2023

Nov 14, 2023

BUY
$6.2 - $9.34 $46,500 - $70,050
7,500 Added 38.66%
26,900 $188,000
Q2 2023

Aug 14, 2023

SELL
$8.76 - $11.92 $231,264 - $314,688
-26,400 Reduced 57.64%
19,400 $178,000
Q1 2023

May 15, 2023

BUY
$10.44 - $12.49 $375,840 - $449,640
36,000 Added 367.35%
45,800 $507,000
Q4 2022

Feb 14, 2023

BUY
$8.01 - $11.35 $78,498 - $111,230
9,800 New
9,800 $104,000

Others Institutions Holding EDAP

About EDAP TMS SA


  • Ticker EDAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,145,300
  • Market Cap $89.3M
  • Description
  • EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWav...
More about EDAP
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.